https://www.selleckchem.com/products/cb-5339.html
ify the specific mechanisms underlying allergic inflammation after PD-1 blockade. We present a rare case in which a patient with cancer was diagnosed with eosinophilic granulomatosis with polyangiitis following treatment with a PD-1 inhibitor. Blockade of PD-1 and the programmed cell death ligand (PD-L) 1/PD-1 and PD-L2/PD-1 signaling cascade may cause allergic inflammation. Further studies are needed to identify the specific mechanisms underlying allergic inflammation after PD-1 blockade. First-year students entering postsecondary educ
Like
Comment
Share
